Find in Library

950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melanoma

oleh: Hong Liu, Kim Margolin, Antoni Ribas, Adil Daud, Mohammed Milhem, Elizabeth Buchbinder, Geoffrey Gibney, Jason Luke, Diwakar Davar, Takami Sato, Bartosz Chmielowski, Luping Zhao, Yousef Zakharia, Theresa Medina, John Kirkwood, Jiaxin Niu, Anthony Olszanski, Montaser Shaheen, George Weiner, Arthur Krieg, Inderjit Mehmi, Heather Kelley, James Wooldridge, Dmitri Bobilev